Researchers from Hospital Clínic-IDIBAPS are leading a study that provides new evidence regarding the benefits and risks of corticosteroid treatment,1
During the “PKU”liar day, held on 28 June, the latest advances in the disease were presented and workshops were organised aimed at patients and famil1
The administration of the antibody mavrilimumab in conjunction with prednisone reduces the risk of exacerbation of symptoms of the disease and improv1
Researchers from the Hospital Clínic-IDIBAPS and the CIBERSAM participate in a study that evidences the involvement of numerous genes in the developm1
This award, worth 35,000 euros, recognises the researcher’s contribution to clinical research in diet and nutrition.
The deadline for applications is the 28th August and 2 of the 15 fellows will be hired by IDIBAPS.
The visit is part of a new communication project aimed at raising awareness of the research carried out at the Institute among patients and patient a1
The partnership aims to improve current characterization and research practices of this disease.
ISO 9001 Quality Management System Requirements is the nationally and internationally recognized quality standard based on continuous process improve1
Last May, three international experts carried out an audit to evaluate the Institute's human resources performance. Nearly 40 research and management1
